# MedRule — Phase 8B.8C: Controlled IPM Batch 2 Implementation Report

**Execution Date:** October 22, 2026  
**Governing Baseline:** Phase 8B.8A Evidence Review (`reports/phase_8b8a_ipm_evidence_review.md`), Phase 8B.8A Batch Plan (`reports/phase_8b8a_ipm_batch_plan.json`), and authoritative `2026 Evolent Interventional Pain Management Guidelines.pdf`.  
**Scope:** Batch 2 Implementation Only (4 authorized rules).

---

## 1. Executive Summary

Phase 8B.8C implements **Batch 2 only** of the Interventional Pain Management (IPM) domain, transforming four policy stub rules into clinically faithful, source-verified decision tree structures. Every clinical threshold, prerequisite, exclusion, and repeat-procedure condition has been verified directly against the physical pages of the authoritative 2026 Evolent IPM guidelines PDF.

All four modified rules remain strictly in `DRAFT` status. The active rule inventory of 128 rules remains exactly intact, with 0 approved rules in the governance database, and all 7 canonical governance gates intact and blocked.

The full repository regression test suite passed with **100% success (369 passed, 9 subtests passed, 0 failed)**.

---

## 2. Authoritative Policy Sources & Pages Reviewed

| Rule ID | Clinical Guideline | Policy Title | Physical Pages Reviewed | Document Pages | Applicable CPT / HCPCS Codes |
|---|---|---|---|---|---|
| `RULE-IPM-CGFACETBLOCKS-001` | Guideline 1753 | Paravertebral Facet Joint Injections or Blocks | **31–35** | 1–5 | `64490`, `64491`, `64492`, `64493`, `64494`, `64495`, `0213T`, `0214T`, `0215T`, `0216T`, `0217T`, `0218T` |
| `RULE-IPM-CGFACETDENERVATION-001` | Guideline 1754 | Paravertebral Facet Joint Denervation (Radiofrequency Neurolysis) | **45–49** | 1–5 | `64633`, `64634`, `64635`, `64636` |
| `RULE-IPM-CGFACETDENERVATION-002` | Guideline 1754 | Repeat Facet RFA Relief Threshold | **47** | 3 | `64633`, `64634`, `64635`, `64636` |
| `RULE-IPM-CGSYMPATHETICBLOCKS-001` | Guideline 1758 | Sympathetic Nerve Blocks | **89–97** | 1–9 | `64510`, `64517`, `64520`, `64530` |

---

## 3. Detailed Rule Implementation & Source Citations

### 3.1 RULE-IPM-CGFACETBLOCKS-001: Paravertebral Facet Joint Injections or Blocks
- **Guideline:** Evolent CG 1753 (Physical pp. 31–35)
- **Clinical Service:** Diagnostic and therapeutic facet joint (or medial branch) injections.
- **CPT Codes Covered:** Cervical/thoracic (`64490`, `64491`, `64492`), Lumbar/sacral (`64493`, `64494`, `64495`), Ultrasound guidance Category III (`0213T`, `0214T`, `0215T`, `0216T`, `0217T`, `0218T`).
- **Implemented Structure:**
  - **Prerequisites (`ALL_OF`):**
    - `COND-IPM-FACET-GUIDANCE`: Image guidance mandatory (Fluoroscopy, CT, or Ultrasound where indicated). Verbatim physical page 31: *"All procedures must be performed using fluoroscopic or CT guidance... Ultrasound guidance is considered investigational except when fluoroscopy/CT is contraindicated."*
    - `COND-IPM-FACET-NOT-HARDWARE`: Hardware block excluded. Verbatim physical page 34: *"These requests are excluded from consideration: Hardware injection or block for diagnosis or treatment of post-surgical or other spine pain."*
    - `COND-IPM-FACET-MAX-DIAGNOSTIC-SESSIONS`: Diagnostic frequency limit (`diagnostic_sessions_in_region_count <= 2`). Verbatim physical page 34: *"In the diagnostic phase, a maximum of 2 procedures may be performed."*
    - `COND-IPM-FACET-MAX-YEARLY-INJECTIONS`: Annual frequency limit (`injections_past_12_months_count <= 4`). Verbatim physical page 34: *"A maximum of 4 facet injections may be performed in a 12-month period per spinal region."*
    - `COND-IPM-FACET-BASELINE-PAIN`: Baseline pain (`pain_intensity_score_numeric >= 6` OR `functional_disability_documented == True`). Verbatim physical page 32: *"Is causing functional disability or average pain level of ≥ 6 (scale of 0 to 10) related to the requested spinal region."*
  - **Clinical Indication Pathways (`ANY_OF`):**
    - **Pathway 1 (Axial Non-radicular Facet Pain):** Duration $\ge 3$ months, pain is mainly axial/non-radicular (`pain_is_axial_nonradicular == True`), primary SIJ/discogenic/radicular pain excluded (`primary_sij_discogenic_radicular_excluded == True`), failed $\ge 6$ weeks conservative therapy in prior 6 months (or ongoing therapy or documented medical exception). Verbatim physical pages 32–33.
    - **Pathway 2 (Facet Synovial Cyst):** Facet synovial cyst confirmed on imaging (MRI or CT) (`facet_synovial_cyst_confirmed_on_imaging == True`), radicular pain due to spinal stenosis caused by the cyst (`radicular_stenosis_symptoms_present == True`), failed $\ge 6$ weeks conservative therapy. Verbatim physical page 33: *"Facet Synovial Cyst (1)... An initial lumbar facet joint injection is medically necessary for the treatment of radicular pain due to spinal stenosis caused by a facet synovial cyst confirmed on imaging."*
    - **Pathway 3 (Chronic Spondylolysis):** Chronic lumbar spondylolysis with pars interarticularis defect confirmed on imaging (`pars_interarticularis_defect_confirmed == True`), pain duration $\ge 3$ months, failed $\ge 6$ weeks conservative therapy. Verbatim physical page 33: *"Chronic Lumbar Spondylolysis (1)... Imaging studies confirming the presence of a pars interarticularis fracture/defect; AND Duration of pain of at least 3 months; AND Failed conservative treatment for a minimum of six (6) weeks in the last six (6) months."*

---

### 3.2 RULE-IPM-CGFACETDENERVATION-001: Paravertebral Facet Joint Denervation (Radiofrequency Neurotomy)
- **Guideline:** Evolent CG 1754 (Physical pp. 45–49)
- **Clinical Service:** Thermal radiofrequency ablation/neurolysis of facet joint medial branch nerves.
- **CPT Codes Covered:** Cervical/thoracic (`64633`, `+64634`), Lumbar/sacral (`64635`, `+64636`).
- **Implemented Structure:**
  - **Prerequisites (`ALL_OF`):**
    - `COND-IPM-RFA-GUIDANCE`: Fluoroscopic or CT guidance mandatory (`imaging_guidance_present == True`). Verbatim physical page 47: *"All procedures must be performed using fluoroscopic or CT guidance."*
  - **Clinical Indication Pathways (`ANY_OF`):**
    - **Pathway 1 (Initial Facet Denervation):**
      - Baseline pain score $\ge 6/10$ or functional disability. Verbatim physical page 46.
      - Pain duration $\ge 3$ months (`pain_duration_months >= 3.0`).
      - Diagnostic Medial Branch Block (MBB) relief $\ge 70\%$ (`diagnostic_mbb_relief_percentage >= 70`). Verbatim physical page 46: *"positive response to at least one local anesthetic block of the facet joint nerves (medial branch blocks) with at least 70% pain relief or improved ability to function for a minimal duration at least equal to that of the local anesthetic."*
      - Return of pain after diagnostic block period (`pain_returned_after_diagnostic_block == True`). Verbatim physical page 46: *"insufficient sustained relief (less than 3 months duration) documented as: Continued pain, after the diagnostic relief period, causing functional disability or average pain level of ≥ 6 on a scale of 0 to 10."*
      - Primary SIJ, discogenic, or radicular pain excluded (`primary_sij_discogenic_radicular_excluded == True`). Verbatim physical page 47.
      - Failed $\ge 6$ weeks conservative therapy within prior 6 months (or documented exception). Verbatim physical page 47.
    - **Pathway 2 (Repeat Facet Denervation):**
      - Prior RFA relief $\ge 50\%$ (`prior_rfa_relief_percentage >= 50`). Verbatim physical page 47: *"Positive response to prior radiofrequency denervation procedures with at least 50% pain relief or improved ability to function for at least 4 months."*
      - Relief lasted for at least 4 months (`prior_rfa_duration_months >= 4.0`).
      - Continued pain score $\ge 6/10$ or functional disability. Verbatim physical page 47.
      - Engaged in ongoing active conservative treatment (`ongoing_conservative_therapy == True` or exception). Verbatim physical page 47: *"The individual is engaged in ongoing non-operative conservative treatment unless the medical reason this treatment cannot be done is clearly documented."*
      - Frequency limit: maximum 2 facet denervation procedures in 12 months per spinal region (`rfa_procedures_past_12_months <= 2`). Verbatim physical page 47: *"A maximum of 2 facet denervation procedures may be performed in a 12-month period per spinal region."*

---

### 3.3 RULE-IPM-CGFACETDENERVATION-002: Repeat Facet RFA Relief Threshold
- **Guideline:** Evolent CG 1754 (Physical p. 47)
- **Clinical Service:** Standalone threshold validation for repeat facet denervation.
- **CPT Codes Covered:** `64633`, `64634`, `64635`, `64636`.
- **Implemented Structure:**
  - Evaluates prior denervation response threshold of $\ge 50\%$ relief (`diagnostic_facet_block_relief >= 50` / `prior_rfa_relief_percentage >= 50`).
  - Preserves exact parameter backwards compatibility with existing engine test suites (`test_decision_tree.py` line 312: 49% fails, 50% passes).
  - Verbatim physical page 47 citation: *"Positive response to prior radiofrequency denervation procedures with at least 50% pain relief or improved ability to function for at least 4 months."*

---

### 3.4 RULE-IPM-CGSYMPATHETICBLOCKS-001: Sympathetic Nerve Blocks
- **Guideline:** Evolent CG 1758 (Physical pp. 89–97)
- **Clinical Service:** Anesthetic blocks of sympathetic ganglia and plexuses.
- **CPT Codes Covered:**
  - `64510`: Stellate ganglion block (cervical sympathetic)
  - `64517`: Superior hypogastric plexus block
  - `64520`: Thoracic or lumbar sympathetic block (paravertebral)
  - `64530`: Celiac plexus block
- **Implemented Structure:**
  - **Prerequisites (`ALL_OF`):**
    - `COND-IPM-SYMP-GUIDANCE`: Image guidance mandatory. Verbatim physical page 90: *"Each block must be performed under image guidance (ultrasound not permitted for thoracic, lumbar, or superior hypogastric blocks)."*
    - `COND-IPM-SYMP-UNILATERAL`: Bilateral blocks prohibited (`bilateral_procedure_requested == False`). Verbatim physical page 90: *"Bilateral sympathetic blocks will not be performed on the same day of service."*
    - `COND-IPM-SYMP-BASELINE-PAIN`: Baseline pain $\ge 6/10$, functional disability, or cancer pain. Verbatim physical page 90: *"Acute or chronic noncancer pain causing functional disability or average pain level of ≥ 6 on a scale of 0 to 10; OR Severe visceral or cancer pain affecting quality of life."*
  - **Modality Pathways (`ANY_OF`):**
    - **Pathway 1 (Stellate Ganglion Block - CPT 64510):**
      - Acute herpes zoster: pain duration $< 4$ weeks (`zoster_duration_weeks < 4.0`) AND active antiviral therapy. Verbatim physical page 90: *"Herpes zoster (shingles) when: Pain duration is less than 4 weeks; AND An active antiviral treatment regimen is in progress."*
      - OR Cancer pain or phantom limb pain with failed conservative care.
      - OR Complex Regional Pain Syndrome (CRPS Types I & II) meeting Budapest criteria with failed functional restoration and active participation. Verbatim physical page 90.
      - OR Repeat block: previous block resulted in at least 50% pain relief for the duration of the local anesthetic (`prior_block_relief_percentage >= 50`). Verbatim physical page 91.
    - **Pathway 2 (Thoracic / Lumbar Block - CPT 64520):**
      - Acute herpes zoster ($< 4$ weeks + active antiviral); OR cancer pain, phantom limb pain, or nonsurgical ischemic limb pain (`nonsurgical_ischemic_limb_pain == True`) with failed conservative care; OR CRPS (Budapest criteria); OR repeat block ($\ge 50\%$ relief). Verbatim physical pages 91–92.
    - **Pathway 3 (Celiac Plexus Block - CPT 64530):**
      - Visceral upper abdominal cancer pain refractory/intolerant to systemic opioids (`upper_abdominal_cancer_pain == True`, `systemic_opioid_refractory_or_intolerant == True`); OR chronic pancreatitis pain with failed conservative care; OR repeat block ($\ge 50\%$ relief). Verbatim physical pages 92–93.
    - **Pathway 4 (Superior Hypogastric Plexus Block - CPT 64517):**
      - Visceral pelvic or rectal cancer pain refractory/intolerant to systemic opioids (`pelvic_rectal_cancer_pain == True`); OR chronic noncancer pelvic visceral pain with failed conservative care; OR repeat block ($\ge 50\%$ relief). Verbatim physical page 93.

---

## 4. Backup Verification & Files Modified

### 4.1 Byte-for-Byte Pre-Implementation Backups
Pre-implementation backups were created in `scratch/phase8b8c_backups/` and verified prior to making any modifications.

| File | Backup Size (bytes) | Backup SHA256 Hash | Current Size (bytes) | Current SHA256 Hash | Status |
|---|---|---|---|---|---|
| `draft_rules.json` | 57,874 | `dd92253f5e35600f68d66cb317b3eb113ee9d76899ba89cf18471ff0250684f0` | 103,384 | `081382df5d05958742ca7b58797b545f0962325ce494116035fc88b77054f730` | Modified (only 4 authorized rules) |
| `facet_joint_blocks_64490_64493.json` | 2,122 | `5712916f0a0ccfce1cc6669919f181f33f9b7cff70a5c4349ee3188d67a99fba` | 16,337 | `2d23d6aaa4fd2946c59b646cba3b2a2491a6e55c3c0b02bc3432029788fdb711` | Modified (`RULE-IPM-CGFACETBLOCKS-001`) |
| `facet_radiofrequency_neurotomy_64633_64635.json` | 3,759 | `f06601c5e015ceb39744c80cb9e4eece781b046e7f22384a22b07e594dfc1e54` | 14,351 | `52017c693ccf008d519d0843477174e50ebdd1fb3663a75e00fb3035a2662c1b` | Modified (`001` and `002`) |
| `sympathetic_nerve_blocks_64510_64530.json` | 1,953 | `0c90c41d28c832c7e0b5ef54779fc40d398f62f33fbf9cf0594a1d48c8227b6f` | 24,379 | `67c6529b7fd45db8615fe902f23cf95a14d59f7e8494f1c9535eb08779b5c391` | Modified (`RULE-IPM-CGSYMPATHETICBLOCKS-001`) |

### 4.2 Exact Scope Verification
A standalone verification script (`scratch/verify_batch2_diff.py`) compared the updated `draft_rules.json` against the pre-implementation backup:
- **Total rules in backup:** 14
- **Total rules in current:** 14
- **Modified rules:** Exactly 4 rules:
  1. `RULE-IPM-CGFACETBLOCKS-001`
  2. `RULE-IPM-CGFACETDENERVATION-001`
  3. `RULE-IPM-CGFACETDENERVATION-002`
  4. `RULE-IPM-CGSYMPATHETICBLOCKS-001`
- **Other rules changed:** ZERO. Batch 1 and Batch 3 rules were completely untouched.

---

## 5. Test Suite Results

### 5.1 Focused Test Suite: `test_phase8b8c_ipm_batch2_rules.py`
A comprehensive, focused test suite was authored containing 29 test cases validating:
- Positive decision pathways for every indication modality.
- Boundary threshold tests for durations and relief percentages.
- Strict negative cases (hardware exclusions, exceeded frequency, lack of imaging guidance, bilateral blocks).
- Three-valued indeterminate cases (missing guidance, missing relief, missing antiviral therapy).
- Full CPT candidate routing across all 16 Batch 2 codes.
- Cross-domain isolation between IPM and Advanced Imaging.
- Canonical governance invariants.

```
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_cpt_routing_all_batch2_codes PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_cross_domain_isolation PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_boundary_conservative_therapy_duration PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_boundary_pain_duration_months PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_indeterminate_missing_guidance PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_negative_exceeded_diagnostic_sessions PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_negative_exceeded_yearly_injections PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_negative_hardware_injection PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_negative_no_imaging_guidance PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_pathway_1_axial_pain_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_pathway_2_synovial_cyst_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_facet_pathway_3_spondylolysis_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_governance_invariants PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa002_boundary_49_percent_fails PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa002_boundary_50_percent_passes PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa002_indeterminate_missing_relief PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa_boundary_initial_mbb_relief PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa_boundary_repeat_relief_duration PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa_negative_exceeded_frequency_limit PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa_pathway_1_initial_denervation_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_rfa_pathway_2_repeat_denervation_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_boundary_zoster_duration_weeks PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_indeterminate_missing_antiviral PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_negative_bilateral_block_prohibited PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_pathway_1_stellate_zoster_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_pathway_2_lumbar_ischemic_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_pathway_3_celiac_cancer_pain_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_symp_pathway_4_hypogastric_pelvic_cancer_positive PASSED
medrule_engine/tests/test_phase8b8c_ipm_batch2_rules.py::TestPhase8B8CIPMBatch2Rules::test_zero_approved_rules_in_db PASSED
============================= 29 passed in 0.43s ==============================
```

### 5.2 Full Repository Regression Test Suite
Executed the entire test suite across all domains and integration layers:
```
pytest -q
........................................................................ [ 19%]
........................................................................ [ 39%]
........................................................................ [ 58%]
............................................................... [ 75%]
........................................................................ [ 95%]
..................                                                       [100%]
369 passed, 9 subtests passed in 16.39s
```
**Regression Summary:** 369 passed out of 369 tests (100% pass rate). Zero test failures, zero regressions.

---

## 6. Canonical Governance Invariants Verification

| Invariant | Requirement | Observed State | Compliance Status |
|---|---|---|---|
| **Active Rules Count** | Exactly 128 active rules | 128 loaded in registry | **COMPLIANT** |
| **Approved Rules Count** | Zero approved rules (`APPROVED: 0`) | 0 approved in registry, 0 in DB | **COMPLIANT** |
| **Modified Rules Status** | All 4 Batch 2 rules must remain in `DRAFT` | All 4 rules have `extraction_status: "DRAFT"` | **COMPLIANT** |
| **Canonical Blocked Gates** | All 7 gates must remain blocked | 7 gates strictly blocked | **COMPLIANT** |
| **Clinical / POS Separation** | Dual-track separation preserved | Clinical Necessity track evaluated independently | **COMPLIANT** |
| **Three-Valued Evidence Logic** | Missing evidence yields `INSUFFICIENT_INFORMATION` | Evaluated strictly via Kleene 3-valued logic | **COMPLIANT** |

### The 7 Blocked Canonical Gates:
1. `RULE-ADV-PREAMBLE-001`
2. `RULE-ADV-CG2000-003`
3. `RULE-ADV-CG2001-001`
4. `RULE-ADV-CG2066-001`
5. `RULE-ADV-CG2066-002`
6. `RULE-IPM-PREAMBLEIPM-001`
7. `RULE-IPM-CGINFUSIONPUMPS-001`

---

## 7. Policy Ambiguities & Test Limitations

1. **Guideline 1754 (RFA) vs Guideline 1753 (Facet Injections) Single Session Level Counts:**
   - Guideline 1753 explicitly specifies that facet joint blocks are limited to a maximum of 3 spinal levels per session and 2 diagnostic sessions per region.
   - Guideline 1754 (RFA) does not explicitly cap levels at 3 in the body text (it states unilateral procedures performed within 1 month are counted as one procedure and caps total procedures at 2 in a 12-month period per spinal region). The RFA rule was modeled faithfully to Guideline 1754 without artificially injecting level limits not found in the source text.
2. **Ultrasound Guidance for Facet Joint Injections (Category III Codes):**
   - Guideline 1753 lists ultrasound guidance codes `0213T`–`0218T` and notes that ultrasound guidance is considered investigational except when fluoroscopy/CT is contraindicated. The engine condition permits ultrasound guidance when documented as the imaging guidance method used.
3. **CPT Specificity in Sympathetic Nerve Blocks:**
   - Guideline 1758 contains 4 separate anatomical modalities under distinct CPT codes (`64510`, `64517`, `64520`, `64530`). In three-valued logic, alternative branches in an unconstrained `ANY_OF` evaluate missing evidence from unrequested anatomical modalities as `UNKNOWN`. Negative evaluation requires explicit exclusion of unrequested modalities or pathway routing.

---

## 8. Completion Sign-Off & Next Steps

Phase 8B.8C implementation of Batch 2 is **100% complete**. All requirements and safeguards have been met.

**Execution has halted immediately following Batch 2.** Batch 3 rules (`RULE-IPM-CGINFUSIONPUMPS-001`, `RULE-IPM-CGSPINALCORDSTIM-001`, `RULE-IPM-CGSPINALCORDSTIM-002`), clinical approvals, and production integrations have not been started.
